000128850 001__ 128850
000128850 005__ 20240228143352.0
000128850 0247_ $$2doi$$a10.3390/v8050138
000128850 0247_ $$2pmid$$apmid:27213425
000128850 0247_ $$2pmc$$apmc:PMC4885093
000128850 0247_ $$2altmetric$$aaltmetric:7623566
000128850 037__ $$aDKFZ-2017-04863
000128850 041__ $$aeng
000128850 082__ $$a610
000128850 1001_ $$0P:(DE-HGF)0$$aJosupeit, Rafael$$b0$$eFirst author
000128850 245__ $$aPediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.
000128850 260__ $$aBasel$$bMDPI$$c2016
000128850 3367_ $$2DRIVER$$aarticle
000128850 3367_ $$2DataCite$$aOutput Types/Journal article
000128850 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1526284096_8683
000128850 3367_ $$2BibTeX$$aARTICLE
000128850 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000128850 3367_ $$00$$2EndNote$$aJournal Article
000128850 520__ $$aCombining virus-induced cytotoxic and immunotherapeutic effects, oncolytic virotherapy represents a promising therapeutic approach for high-grade glioma (HGG). A clinical trial has recently provided evidence for the clinical safety of the oncolytic parvovirus H-1 (H-1PV) in adult glioblastoma relapse patients. The present study assesses the efficacy of H-1PV in eliminating HGG initiating cells. H-1PV was able to enter and to transduce all HGG neurosphere culture models (n = 6), including cultures derived from adult glioblastoma, pediatric glioblastoma, and diffuse intrinsic pontine glioma. Cytotoxic effects induced by the virus have been observed in all HGG neurospheres at half maximal inhibitory concentration (IC50) doses of input virus between 1 and 10 plaque forming units per cell. H-1PV infection at this dose range was able to prevent tumorigenicity of NCH421k glioblastoma multiforme (GBM) 'stem-like' cells in NOD/SCID mice. Interestingly NCH421R, an isogenic subclone with equal capacity of xenograft formation, but resistant to H-1PV infection could be isolated from the parental NCH421k culture. To reveal changes in gene expression associated with H-1PV resistance we performed a comparative gene expression analysis in these subclones. Several dysregulated genes encoding receptor proteins, endocytosis factors or regulators innate antiviral responses were identified and represent intriguing candidates for to further study molecular mechanisms of H-1PV resistance.
000128850 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000128850 588__ $$aDataset connected to CrossRef, PubMed,
000128850 7001_ $$0P:(DE-HGF)0$$aBender, Sebastian$$b1
000128850 7001_ $$0P:(DE-HGF)0$$aKern, Sonja$$b2
000128850 7001_ $$0P:(DE-He78)119d7d540a0e6fc5734898bef4866d7f$$aLeuchs, Barbara$$b3$$udkfz
000128850 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b4$$udkfz
000128850 7001_ $$aHerold-Mende, Christel$$b5
000128850 7001_ $$0P:(DE-HGF)0$$aSchlehofer, Jörg R$$b6
000128850 7001_ $$0P:(DE-He78)349f3daee0a618de13d40851744cf00c$$aDinsart, Christiane$$b7$$udkfz
000128850 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b8$$udkfz
000128850 7001_ $$0P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aRommelaere, Jean$$b9$$udkfz
000128850 7001_ $$0P:(DE-He78)9c8a10405c0a6ffe7941d65e89cb7c61$$aLacroix, Jeannine Ariane Desiree$$b10$$eLast author$$udkfz
000128850 773__ $$0PERI:(DE-600)2516098-9$$a10.3390/v8050138$$gVol. 8, no. 5, p. 138 -$$n5$$p138 -$$tViruses$$v8$$x1999-4915$$y2016
000128850 909CO $$ooai:inrepo02.dkfz.de:128850$$pVDB
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)119d7d540a0e6fc5734898bef4866d7f$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)349f3daee0a618de13d40851744cf00c$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000128850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9c8a10405c0a6ffe7941d65e89cb7c61$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000128850 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000128850 9141_ $$y2016
000128850 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bVIRUSES-BASEL : 2015
000128850 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000128850 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000128850 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000128850 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000128850 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000128850 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000128850 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000128850 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000128850 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000128850 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000128850 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000128850 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000128850 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000128850 9201_ $$0I:(DE-He78)F010-20160331$$kF010$$lTumorvirologie$$x0
000128850 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x1
000128850 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x2
000128850 9201_ $$0I:(DE-He78)G340-20160331$$kG340$$lKKE Pädiatrische Onkologie$$x3
000128850 980__ $$ajournal
000128850 980__ $$aVDB
000128850 980__ $$aI:(DE-He78)F010-20160331
000128850 980__ $$aI:(DE-He78)B062-20160331
000128850 980__ $$aI:(DE-He78)C060-20160331
000128850 980__ $$aI:(DE-He78)G340-20160331
000128850 980__ $$aUNRESTRICTED